2022 Comprehensive Covid-19 Guide https://www.cms.gov/files/document/covid-provider-counseling-qa.pdf
CMS also provides a Talking Points document to guide providers in conversing with patients about selfisolating. We provide a link and an excerpt below: https://www.cms.gov/files/document/covid-provider-patient-counseling-talking-points.pdf
COVID-19 Lab Tests Code selection depends on the payer and the test performed. Contact your local third-party payer directly to determine their specific reporting guidelines. For Medicare, report the code that matches the test source (CDC or non-CDC) or the technique. CMS offers guidance at the link below: https://www.cms.gov/files/document/03052020-medicare-covid-19-fact-sheet.pdf
HCPCS
Description
Effective Date
U0001
CDC 2019 Novel Coronavirus (2019-nCoV) Real-Time RT-PCR Diagnostic Panel
02-04-2020
U0002
2019-nCoV Coronavirus, SARS-CoV-2/2019-nCoV (COVID-19), any technique, multiple types or subtypes (includes all targets), non-CDC
02-04-2020
0202U
Infectious disease (bacterial or viral respiratory tract infection), pathogenspecific nucleic acid (DNA or RNA), 22 targets including severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), qualitative RT-PCR, nasopharyngeal swab, each pathogen reported as detected or not detected
05-20-2020
(PARA note: Proprietary lab analysis test – PLA – BioFire® Respiratory Panel 2.1 (RP2.1), BioFire®Diagnostics, LLC)
(continues next page) © 2022 PARA HealthCare Analytics, an HFRI Company – January 2022 CPT® is a registered trademark of the American Medical Association
Page 20
